Table 2.

Lab results over time for all patients.

	Baseline	3 Month	6 Month	9 Month	12 Month
Erythrocyte protoporphyrin (μg/dL) – Number of observations; Median (IQR); Range
EPP	13; 1561 (1110, 2589); 708–8054	12; 1823.5 (1201, 4323); 910–8695	9; 1357 (1114, 3919); 897–8885	8; 1191.5 (927.5, 3728); 792–8504	8; 1611.5 (830, 3454); 793–8042
XLP	3; 1857 (1705, 2440); 1705–2440	3; 1571 (1338, 1810); 1338–1810	2; 1102 (611, 1593); 611–1593	2; 1170.5 (942, 1399); 942–1399	2; 889 (560, 1218); 560–1218
Iron (μg/dL) - Number of observations; Median (IQR); Range
EPP	12; 78.5 (53, 85); 32–107	11; 123 (86, 135); 36–223	8; 91.5 (71, 130.5); 41–162	8; 95.5 (60, 139.5); 27–182	6; 105 (84, 131); 54–137
XLP	3; 102 (57, 102); 57–102	3; 123 (104, 145); 104–145	2; 129 (120, 138); 120–138	2; 129 (101, 157); 101–157	2; 107.5 (107, 108); 107–108
Ferritin (ng/mL) - Number of observations; Median (IQR); Range
EPP	13; 19.1 (13, 24); 4–29	11; 40 (29, 55); 4–75	8; 42.8 (23.7, 51); 6–59	8; 39.6 (33, 50.8); 4–67	8; 36.5 (22, 57.7); 5–77
XLP	3; 24 (18.4, 26.6); 18.4–26.6	3; 25.1 (23.2, 29); 23.2–29	2; 39.1 (37.7, 40.5); 37.7–40.5	2; 57.1 (50.4, 63.8); 50.4–63.8	2; 48.3 (39.6, 56.9); 39.6–56.9
Transferrin Saturation (%)- Number of observations; Median (IQR); Range
EPP	11; 19.0 (17.0, 25.0); 6.0–31.0	11; 33.0 (25.0, 41.0); 7.0–56.0	8; 25.5 (16.5, 40.0); 13.0–50.0	8; 25.0 (17.5, 38.5); 6.0–60.0	6; 32.0 (25.0, 38.0); 17.0–41.0
XLP	3; 25.0 (18.0, 28.0); 18.0–28.0	2; 36.5 (31.0, 42.0); 31.0–42.0	2; 36.0 (35.0, 37.0); 35.0–37.0	2; 38.0 (28.0, 48.0); 28.0–48.0	2; 30.0 (29.0, 31.0); 29.0–31.0
Plasma Porphyrins (μg/dL) - Number of observations; Median (IQR); Range
EPP	13; 4.1 (1.4, 5.6); 0.5–24	12; 5.4 (3.4, 9.5); 0.9–35.8	9; 5.1 (3.9, 8.2); 1.2–12.6	8; 4.1 (2.8, 7.6); 0.4–16.2	8; 4.2 (2.2, 8.9); 0.7–16.9
XLP	3; 1.4 (0.5, 1.7); 0.5–1.7	3; 2 (0.8, 2.3); 0.8–2.3	2; 1.6 (1.6, 1.6); 1.6–1.6	2; 1.8 (0.7, 2.9); 0.7–2.9	2; 1.2 (1, 1.3); 1–1.3
Hemoglobin (g/dL) - Number of observations; Median (IQR); Range
EPP	13; 12.5 (12, 13.7); 8.6–14.2	12; 13.1 (12.2, 13.7); 11.6–14.9	8; 12.6 (12.1, 13.9); 11.5–14.8	8; 12.9 (12.2, 13.6); 11.5–15	8; 12.6 (11.7, 13.8); 11.3–15
XLP	3; 12.4 (11.8, 14.2); 11.8–14.2	3; 12.4 (12, 13.5); 12–13.5	2; 13.3 (12.9, 13.6); 12.9–13.6	2; 13.8 (13.5, 14.1); 13.5–14.1	2; 13.7 (13.5, 13.9); 13.5–13.9
AST (U/L) - Number of observations; Median (IQR); Range
EPP	13; 21 (18, 28); 14–36	11; 29 (19, 38); 14–41	8; 25.5 (19.5, 28.5); 16–36	8; 19.5 (17, 24.5); 15–32	8; 22 (17.5, 24); 14–27
XLP	3; 23 (19, 31); 19–31	3; 23 (20, 27); 20–27	2; 26.5 (24, 29); 24–29	2; 26.5 (24, 29); 24–29	2; 15 (14, 16); 14–16
ALT (U/L) - Number of observations; Median (IQR); Range
EPP	13; 27 (19, 33); 10–78	11; 27 (16, 41); 12–93	8; 27.5 (22, 39.5); 17–55	8; 23 (17, 26); 15–33	8; 21.5 (16.5, 26.5); 16–42
XLP	3; 27 (16, 27); 16–27	3; 28 (20, 37); 20–37	2; 33 (28, 38); 28–38	2; 30.5 (26, 35); 26–35	2; 22.5 (17, 28); 17–28